(Q44550796)

4 December 2017

title

Paroxetine-induced increase in metabolic end products of nitric oxide (English)

1 reference

4 December 2017

Paroxetine-Induced Increase in Metabolic End Products of Nitric Oxide (English)

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

3 April 2024

1 reference

ChEBI release 2020-05-28

Nathalie Lara

1

1 reference

4 December 2017

Jean-Michel Le Mellédo

4

1 reference

4 December 2017

Stephen L. Archer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624192

3 April 2024

Glen B. Baker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624192

3 April 2024

language of work or name

English

0 references

publication date

1 August 2003

1 reference

4 December 2017

December 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14624192

full work available at URL

3 April 2024

http://journals.lww.com/00007632-200309010-00012

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Journal of Clinical Psychopharmacology

3 April 2024

published in

1 reference

4 December 2017

volume

23

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

408-412

1 reference

Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy

4 December 2017

cites work

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1161/01.CIR.99.16.2192

Nitric oxide: a physiologic messenger molecule

1

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Nitric oxide synthase: models and mechanisms

3 April 2024

2

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein

3 April 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

The L-arginine-nitric oxide pathway

3 April 2024

4

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients

3 April 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans

3 April 2024

6

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults

3 April 2024

7

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Measurement of nitric oxide in biological models.

3 April 2024

8

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up

3 April 2024

10

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance

3 April 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Paroxetine: an update of its use in psychiatric disorders in adults

3 April 2024

12

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Endothelial dysfunction in human disease

3 April 2024

14

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments

3 April 2024

15

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Effect of dietary control on plasma nitrate level and estimation of basal systemic nitric oxide production rate in humans.

3 April 2024

16

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Effects of diet on measurement of nitric oxide metabolites

3 April 2024

17

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection

3 April 2024

19

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Differential nitric oxide synthase activity in ischemic and idiopathic dilated cardiomyopathy

3 April 2024

20

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Negative NO3- difference in human coronary circulation with severe atherosclerotic stenosis

3 April 2024

21

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Atherothrombosis: plaque instability and thrombogenesis

3 April 2024

23

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Platelet reactivity in depressed patients treated with paroxetine: preliminary findings

3 April 2024

25

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment

3 April 2024

26

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.

3 April 2024

27

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes

3 April 2024

28

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement

3 April 2024

29

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Platelet activation in depression and effects of sertraline treatment: An open-label study

3 April 2024

31

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Selective serotonin reuptake inhibitors and myocardial infarction

3 April 2024

33

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Sertraline treatment of major depression in patients with acute MI or unstable angina

3 April 2024

34

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans

3 April 2024

35

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

Elevated plasma nitrate levels in depressive states

3 April 2024

36

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000085416.08426.1D

3 April 2024

Identifiers

1 reference

4 December 2017

1 reference

4 December 2017